MAIA Biotechnology Inc.
Organization details
- Legal name
- MAIA Biotechnology Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Chicago
- Headquarters state / province
- Illinois
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- MAIA
- Primary stock exchange
- NYSE American
Identifiers
- SEC CIK
- 0001878313
Board of directors
-
Cristian Luput · DirectorSince 2023
-
Jean-Manasse Theagene · DirectorSince 2023
-
Laurentiu Vlad · DirectorSince 2023
-
Ngar Yee Louie · DirectorSince 2023
-
Ramiro Guerrero · DirectorSince 2023
-
Stan Smith · DirectorSince 2023
-
Steven M. Chaouki · DirectorSince 2023
-
Vlad Vitoc · Director · Chief Executive OfficerSince 2023
Chief executives
Director election results
Annual meeting of May 22, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
90.9%
-
95.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $985,983
- 27 purchases by 7 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 14, 2026 | Vlad Vitoc Director, Officer (Chief Executive Officer), 10% owner | Open-market purchase | +73,000 | $1.37 | $100,010 |
| Sep 10, 2026 | Ramiro Guerrero Director | Open-market purchase | +37,595 | $1.32 | $49,625 |
| Aug 28, 2026 | Ramiro Guerrero Director | Open-market purchase | +46,620 | $1.35 | $62,937 |
| Aug 27, 2026 | Ramiro Guerrero Director | Open-market purchase | +78,239 | $1.39 | $108,752 |
| Aug 26, 2026 | Ramiro Guerrero Director | Open-market purchase | +8,931 | $1.39 | $12,414 |
| Aug 24, 2026 | Ramiro Guerrero Director | Open-market purchase | +1,794 | $1.33 | $2,386 |
| Aug 20, 2026 | Ramiro Guerrero Director | Open-market purchase | +11,899 | $1.37 | $16,302 |
| Jun 1, 2026 | Vlad Vitoc Director, Officer (Chief Executive Officer), 10% owner | Open-market purchase | +72,700 | $1.39 | $101,053 |
| Jun 1, 2026 | Stan Smith Director | Open-market purchase | +75,000 | $1.34 | $100,500 |
| Jun 1, 2026 | Gryaznov Sergei Officer (Chief Scientific Officer) | Open-market purchase | +2,000 | $1.35 | $2,700 |
| Dec 22, 2025 | Stan Smith Director | Open-market purchase | +57,189 | $1.22 | $69,771 |
| Dec 22, 2025 | Steven M. Chaouki Director | Open-market purchase | +40,849 | $1.22 | $49,836 |
| Dec 22, 2025 | Ngar Yee Louie Director | Open-market purchase | +81,699 | $1.22 | $99,673 |
| Dec 5, 2025 | Stan Smith Director | Open-market purchase | +4,580 | $1.20 | $5,496 |
| Dec 5, 2025 | Stan Smith Director | Open-market purchase | +4,580 | $1.19 | $5,450 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about MAIA Biotechnology Inc.
Who is the CEO of MAIA Biotechnology Inc.?
Vlad Vitoc is MAIA Biotechnology Inc.'s Chief Executive Officer.
How many directors are on MAIA Biotechnology Inc.'s board?
MAIA Biotechnology Inc.'s board has 8 directors: Cristian Luput, Jean-Manasse Theagene, Laurentiu Vlad, Ngar Yee Louie, Ramiro Guerrero, Stan Smith, Steven M. Chaouki and Vlad Vitoc.
Are MAIA Biotechnology Inc. insiders buying or selling shares?
Over the last 12 months, MAIA Biotechnology Inc. insiders bought $985,983 of shares in 27 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="maia-biotechnology-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.